Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D2-like dopamine receptor family comprises D2, D3, and D4 receptor subtypes, all of which are G protein-coupled receptors that bind dopamine. These receptors are primarily Gi/o-coupled, leading to inhibition of adenylyl cyclase activity. They play crucial roles in regulating dopamine release, neuronal excitability, and various behavioral functions, including locomotion, attention, and cognition. The D2 receptor is a primary target for antipsychotic drugs, and alterations in D2-like receptor function have been implicated in neuropsychiatric disorders such as schizophrenia, Parkinson's disease, and ADHD.
Gi/o protein coupling, inhibition of adenylyl cyclase, decreased cAMP production, modulation of ion channels. Antagonism of D2-like receptors to reduce dopamine signaling.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine Receptor D2-like (D2-like Receptor).